Skip to content

Medical-device intelligence

QDJ: Direct-To-Consumer Access Pharmacogenetic Assessment System

FDA product code QDJ: Direct-To-Consumer Access Pharmacogenetic Assessment System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QDJ
FDA device name
Direct-To-Consumer Access Pharmacogenetic Assessment System
Device class
2
Regulation number
862.3364
Medical specialty
Medical Genetics
Review panel
CH

FDA definition

A direct-to-consumer access pharmacogenetic assessment system is a qualitative in vitro molecular diagnostic system used for detecting variants in nucleic acids isolated from human specimens the purpose of identifying pharmacogenetic associations for the detected variants. This device is for in vitro diagnostic use only, and is intended for direct access testing by lay users.
Explore medical genetics records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Aug 17, 2020 to Oct 26, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
23andMe Personal Genome Service (PGS) Pharmacogenetic ReportsK221885 · QDJ23AndMe, Inc.510(k)Oct 26, 2022FDA decision date
23andMe Personal Genome Service (PGS) Pharmacogenetic ReportsK193492 · QDJ23AndMe, Inc.510(k)Aug 17, 2020FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗